Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevirapine and Rifabutin PK Interaction in HIV+ Patients
NCT02184078Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 1998
- Primary completion
- Dec 1998
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of nevirapine in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Started Oct 1998; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02184078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184078.